Why Biotechnology Company Carmell Shares Are Seeing Blue Skies Tuesday?
Why Biotechnology Company Carmell Shares Are Seeing Blue Skies Tuesday?
Carmell Corporation (NASDAQ:CTCX) shares are trading higher after it entered into a securities purchase agreement with new and existing investors.
Carmell Corporation (纳斯达克:CTCX) 股票在与新老投资者签署证券购买协议后交易上涨。
The agreement involves the issuance and sale of 8,065,210 shares of common stock and an equal number of five-year warrants, both priced at $0.23 per share, in a private placement.
该协议涉及发行和出售8,065,210股普通股,以及数量相同的五年期Warrants,二者的售价均为每股$0.23,属于定向增发。
The transaction is expected to generate gross proceeds of $1.85 million before offering expenses and fees.
该交易预计在扣除发行费用和费用之前将产生185万的总收入。
If the warrants are exercised, Carmell could receive an additional $1.85 million.
如果Warrants被行使,Carmell可能会获得额外的185万。
The Private Placement was priced slightly above CTCX's closing price on Dec. 23, 2024.
定向增发的定价略高于2024年12月23日CTCX的收盘价。
Following the closing of the Private Placement, Carmell Corporation will have approximately 29 million shares of common stock outstanding.
在定向增发结束后,Carmell Corporation将拥有约2900万股普通股。
The warrants can be exercised starting the trading day after the Stockholder Approval Date and continue until the fifth anniversary of the warrant issue date.
Warrants可以在股东批准日期后的第一个交易日开始行使,并持续到Warrant发行日期的五周年。
The warrants allow for the purchase of up to 8.1 million shares of Carmell's common stock at an exercise price of $0.23 per share.
这些Warrants允许以每股$0.23的行使价格购买高达810万股Carmell的普通股。
The closing of the Private Placement is subject to customary conditions.
定向增发的完成需满足惯例条件。
Price Action: CTCX shares are up 20% at $0.27 at last check Tuesday.
价格走势:CTCX 股票在周二最后检查时上涨 20%,报 $0.27。
Read Next:
下一步阅读:
- Warren Buffett Heads Into 2025 With $325 Billion Cash Pile, His Largest in Over Three Decades: Expert Says It 'Will Provide An Opportunity For The Successors To Make Their Own Mark'
- 沃伦·巴菲特以3250亿美元的现金储备迈入2025年,这是他三十多年以来的最大现金储备:专家表示,这"将为接班人提供展示自己的机会"
Photo: Shutterstock
Photo: shutterstock